Loss Contingency, Number Of Class Action Suits

No definition available.

Name:	amgn_LossContingencyNumberOfClassActionSuits
Namespace Prefix:	amgn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Number of Lawsuits Filed

+ References

No definition available.

+ Details

Name:	amgn_LossContingencyNumberOfLawsuitsFiled
Namespace Prefix:	amgn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Number Of States In Which Plaintiffs Reside

+ References

No definition available.

+ Details

Name:	amgn_LossContingencyNumberOfStatesInWhichPlaintiffsReside
Namespace Prefix:	amgn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Potential Patent Infringement, Number

+ References

No definition available.

+ Details

Name:	amgn_LossContingencyPotentialPatentInfringementNumber
Namespace Prefix:	amgn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Number of Annual Installments

+ References

No definition available.

+ Details

Name:	amgn_TaxCutsAndJobsActof2017IncompleteAccountingNumberofAnnualInstallments
Namespace Prefix:	amgn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482425/460-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of plaintiffs that have filed claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=amgn_ProliaXGEVABiologicsPriceCompetitionAndInnovationActMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amgn_SensiparAntitrustClassActionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amgn_ChemoCentryxIncSecuritiesMattersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amgn_ABP938PatentLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Contingencies and commitments - Narrative (Details)	1 Months Ended	3 Months Ended
Contingencies and commitments - Narrative (Details)	Jun. 08, 2021 lawsuit	Apr. 30, 2019 lawsuit claim plaintiff	Jan. 10, 2024 patent	Dec. 31, 2023 installment	May 01, 2023 patent	Mar. 11, 2022 state
Loss Contingencies [Line Items]
U.S. repatriation tax commitments, number of annual installments \| installment				8
Prolia/XGEVA Biologics Price Competition And Innovation Act \| Pending Litigation
Loss Contingencies [Line Items]
Potential number of patents infringed upon \| patent					21
Sensipar Antitrust Class Actions \| Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, number of plaintiffs \| plaintiff		4
Number of lawsuits \| claim		2
Loss contingency, number of lawsuits filed \| lawsuit		4
Number of states in which plaintiffs reside \| state						10
ChemoCentryx, Inc. Securities Matters
Loss Contingencies [Line Items]
Number of class action law suits \| lawsuit	2
ABP 938 Patent Litigation \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Potential number of patents infringed upon \| patent			32